ÂÜÀòÂÒÂ×

Melitta Bilban-Jaksche serves as Vice President and Global Program Lead for Plasma-Derived Therapies at Takeda since January 2019, overseeing a pipeline of global programs in Hematology, Immunology, Neurology, and Critical Care. Prior to this role, Melitta held positions including Global Program Lead at Takeda, focusing on Hematology and Immunology, and leadership roles at Shire and Baxter, handling clinical development and due diligence for high-priority programs. Melitta's academic background includes a Ph.D. in Organic Chemistry from Scripps Research and a Dipl.Ing. in Technical Chemistry from Technische Universität Wien.